Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
Tarek Mohamed Abd El‐Aziz, James D. Stockand
Infection Genetics and Evolution (2020) Vol. 83, pp. 104327-104327
Open Access | Times Cited: 365

Showing 1-25 of 365 citing articles:

Meat consumption: Which are the current global risks? A review of recent (2010–2020) evidences
Neus González, Montse Marquès, Martí Nadal, et al.
Food Research International (2020) Vol. 137, pp. 109341-109341
Open Access | Times Cited: 312
DNA vaccines against COVID-19: Perspectives and challenges
Marcelle Moura Silveira, Gustavo Marçal Schmidt Garcia Moreira, Marcelo Mendonça
Life Sciences (2020) Vol. 267, pp. 118919-118919
Open Access | Times Cited: 264
Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review
Susmit Mhatre, Tishya Srivastava, Shivraj Naik, et al.
Phytomedicine (2020) Vol. 85, pp. 153286-153286
Open Access | Times Cited: 240
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development
Kevin Ita
Archives of Medical Research (2020) Vol. 52, Iss. 1, pp. 15-24
Open Access | Times Cited: 160
Pharmaceutical compounds used in the COVID-19 pandemic: A review of their presence in water and treatment techniques for their elimination
Carlos Augusto Morales-Paredes, Joan Manuel Rodríguez-Díaz, Nuria Boluda Botella
The Science of The Total Environment (2021) Vol. 814, pp. 152691-152691
Open Access | Times Cited: 151
SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, et al.
International Journal of Biological Macromolecules (2021) Vol. 188, pp. 740-750
Open Access | Times Cited: 114
A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications
Yanqing Lai, Fan Xia, Hongli Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 104
Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions
Safaet Alam, Md. Moklesur Rahman Sarker, Sadia Afrin, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 104
Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights
Sabeeha Ali, Manzar Alam, Fatima Khatoon, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112658-112658
Open Access | Times Cited: 75
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 64
COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
İlker Polatoğlu, Tülay Öncü Öner, Irem Dalman, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 43
Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment
Sanket Shah, Debashish Danda, Chengappa Kavadichanda, et al.
Rheumatology International (2020) Vol. 40, Iss. 10, pp. 1539-1554
Open Access | Times Cited: 117
COVID-19 Diagnostics, Tools, and Prevention
Mayar Allam, Shuangyi Cai, Shambavi Ganesh, et al.
Diagnostics (2020) Vol. 10, Iss. 6, pp. 409-409
Open Access | Times Cited: 103
The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study
Mobina Fathi, Kimia Vakili, Fatemeh Sayehmiri, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0246190-e0246190
Open Access | Times Cited: 97
A hover view over effectual approaches on pandemic management for sustainable cities – The endowment of prospective technologies with revitalization strategies
Rajvikram Madurai Elavarasan, Rishi Pugazhendhi, GM Shafiullah, et al.
Sustainable Cities and Society (2021) Vol. 68, pp. 102789-102789
Open Access | Times Cited: 87
Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients
Saifuddin Mahmud, Md. Al-Mustanjid, Farzana Akter, et al.
Briefings in Bioinformatics (2021)
Open Access | Times Cited: 85
Tea and coffee polyphenols and their biological properties based on the latest in vitro investigations
Przemysław Liczbiński, Bożena Bukowska
Industrial Crops and Products (2021) Vol. 175, pp. 114265-114265
Open Access | Times Cited: 82
COVID-19: Perspectives for the management of dental care and education
Bruno César de Vasconcelos Gurgel, Samuel Batista Borges, Raul Elton Araújo Borges, et al.
Journal of Applied Oral Science (2020) Vol. 28
Open Access | Times Cited: 74
Considerações sobre o impacto da covid-19 na relação indivíduo-sociedade: da hesitação vacinal ao clamor por uma vacina
Márcia Thereza Couto, Carolina Luísa Alves Barbieri, Camila Carvalho de Souza Amorim Matos
Saúde e Sociedade (2021) Vol. 30, Iss. 1
Open Access | Times Cited: 74
Mental health of healthcare workers during the COVID-19 outbreak: A rapid scoping review to inform provincial guidelines in South Africa
Lesley Robertson, Innocent Maposa, H Somaroo, et al.
South African Medical Journal (2020) Vol. 110, Iss. 10, pp. 1010-1010
Open Access | Times Cited: 73
Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19
Gunjan Arora, Jayadev Joshi, Rahul Shubhra Mandal, et al.
Pathogens (2021) Vol. 10, Iss. 8, pp. 1048-1048
Open Access | Times Cited: 73
Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation
Alireza Paniri, Haleh Akhavan‐Niaki
Life Sciences (2020) Vol. 257, pp. 118114-118114
Open Access | Times Cited: 71
Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19)
Amr El‐Demerdash, Ahmed M. Metwaly, Afnan Hassan, et al.
Biomolecules (2021) Vol. 11, Iss. 3, pp. 460-460
Open Access | Times Cited: 71
A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation
Ahmed Rakib, Zulkar Nain, Saad Ahmed Sami, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 2, pp. 1476-1498
Open Access | Times Cited: 64
A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19
Srikanth Umakanthan, Vijay Kumar Chattu, Anu Vinod Ranade, et al.
AIMS Public Health (2021) Vol. 8, Iss. 1, pp. 137-153
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top